Integra LifeSciences Holdings Corporation

IARTNASDAQHealthcare● Active

$16.94

$-0.05(-0.29%)

Market Cap$1.3B

P/E Ratio—

52W High$17.42

52W Low$8.7

Avg Volume975K

Open$17.00

Beta1.25

Net Income Financials Revenue

Integra LifeSciences Holdings Corporation (IART) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IART · net income · updated Jun 8, 2026

Core profitability metrics

IART · net income · margin · TTM · CAGR

Net income was −$516.5M for FY2025 (fiscal year ending 2025-12-31), down 7337.7% year-over-year. Net profit margin was -31.6%. Based on available data, Integra LifeSciences Holdings Corporation has been profitable since at least 2011.

FY2025 Net Income−$516.5M▼ -7337.7% YoY

Trailing 12M (TTM)−$495.8Mtrailing 4 quarters sum

Net Profit Margin-31.6%−$516.5M ÷ $1.64B

YoY Change-7337.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · IART net income history · IART profit margin

Annual net income data

IART · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$516.5M▼ 7337.7%-31.6%$1.64B

FY2024Loss−$6.9M▼ 110.3%-0.4%$1.61B

FY2023$67.7M▼ 62.5%4.4%$1.54B

FY2022$180.6M▲ +6.8%11.6%$1.56B

FY2021$169.1M▲ +26.3%11.0%$1.54B

Net income vs peers (Healthcare)

IART vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Integra LifeSciences Holdings CorporationYOU

IART

−$516.5M-7337.7%-31.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Integra LifeSciences Holdings Corporation (IART) reported net income of −$516.5M for FY2025 (fiscal year ending 2025-12-31), down 7337.7% year-over-year. The net profit margin was -31.6% — meaning the company kept $-0.32 of every dollar of revenue as profit.

Based on available data, Integra LifeSciences Holdings Corporation has been profitable since at least 2011. Net income reached a peak of $180.6M in FY2022. Data available for 15 fiscal years.

Integra LifeSciences Holdings Corporation's net profit margin was -31.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Integra LifeSciences Holdings Corporation net worth" — the company's market capitalization is a separate figure from IART net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IART net income · 4 questions

Integra LifeSciences Holdings Corporation is not currently profitable on an annual basis. The company reported a net loss of $516.5M for FY2025.

is IART profitabledoes IART make a profitIART profitabilityIART profitable company

▸ Source: FMP /income-statement · GAAP · Integra LifeSciences Holdings Corporation · Integra LifeSciences Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026